2023
Enduring Injustice: Infectious Disease Outbreaks in Carceral Settings
Andrews J, Liu Y, Croda J. Enduring Injustice: Infectious Disease Outbreaks in Carceral Settings. The Journal Of Infectious Diseases 2023, 229: 307-309. PMID: 37493282, PMCID: PMC10873189, DOI: 10.1093/infdis/jiad290.Peer-Reviewed Original ResearchDisease Outbreaks
2020
Genomic variant-identification methods may alter Mycobacterium tuberculosis transmission inferences
Walter KS, Colijn C, Cohen T, Mathema B, Liu Q, Bowers J, Engelthaler DM, Narechania A, Lemmer D, Croda J, Andrews JR. Genomic variant-identification methods may alter Mycobacterium tuberculosis transmission inferences. Microbial Genomics 2020, 6: mgen000418. PMID: 32735210, PMCID: PMC7641424, DOI: 10.1099/mgen.0.000418.Peer-Reviewed Original ResearchEffect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Borba M, Val F, Sampaio V, Alexandre M, Melo G, Brito M, Mourão M, Brito-Sousa J, Baía-da-Silva D, Guerra M, Hajjar L, Pinto R, Balieiro A, Pacheco A, Santos J, Naveca F, Xavier M, Siqueira A, Schwarzbold A, Croda J, Nogueira M, Romero G, Bassat Q, Fontes C, Albuquerque B, Daniel-Ribeiro C, Monteiro W, Lacerda M. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. JAMA Network Open 2020, 3: e208857. PMID: 32330277, DOI: 10.1001/jamanetworkopen.2020.8857.Peer-Reviewed Original ResearchConceptsHigh dosage groupSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionAcute respiratory syndrome coronavirus 2 infectionLow dosage groupSyndrome coronavirus 2 infectionCoronavirus 2 infectionChloroquine diphosphateDay 13COVID-19Phase IIb clinical trialNonsevere COVID-19Secondary end pointsSevere COVID-19High-dose groupSpecific antiviral therapyTertiary care facilityIIb clinical trialCoronavirus disease 2019More heart diseaseParticipants' clinical statusAdjunctive therapyAdult patientsIll patientsPrimary outcomeAntiviral therapy
2017
Seroprevalence of Chikungunya Virus in a Rural Community in Brazil
Cunha R, Trinta K, Montalbano C, Sucupira M, de Lima M, Marques E, Romanholi I, Croda J. Seroprevalence of Chikungunya Virus in a Rural Community in Brazil. PLOS Neglected Tropical Diseases 2017, 11: e0005319. PMID: 28107342, PMCID: PMC5287455, DOI: 10.1371/journal.pntd.0005319.Peer-Reviewed Original ResearchConceptsCases of chikungunyaCHIKV infectionChikungunya virusCHIKV IgMSymptomatic CHIKV infectionIgM-specific antibodiesFeira de SantanaIgG-specific antibodiesEpidemiological surveillance systemBrazilian Epidemiological Surveillance SystemCHIKV IgGModerate seroprevalenceSeropositive patientsJoint painIgG antibodiesCHIKV transmissionFirst serosurveySeroprevalenceInfectionMagnitude of transmissionAntibodiesPatientsFirst caseSerosurveyIgM
2015
Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital
Silva K, Cayô R, Carvalhaes C, Sacchi F, Rodrigues-Costa F, da Silva A, Croda J, Gales A, Simionatto S. Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital. Journal Of Clinical Microbiology 2015, 53: 2324-2328. PMID: 25878341, PMCID: PMC4473237, DOI: 10.1128/jcm.00727-15.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAnti-Bacterial AgentsBeta-Lactam ResistanceBeta-LactamasesBrazilCarbapenemsChild, PreschoolCross InfectionDisease OutbreaksDNA, BacterialFemaleGenes, BacterialHospitals, TeachingHumansInfantIntegronsMaleMicrobial Sensitivity TestsMiddle AgedMinocyclineMolecular Sequence DataPlasmidsSequence Analysis, DNASerratia InfectionsSerratia marcescensTigecycline
2014
Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines
Machado A, Estevan A, Sales A, da Silva Brabes K, Croda J, Negrão F. Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines. PLOS Neglected Tropical Diseases 2014, 8: e3104. PMID: 25188295, PMCID: PMC4154670, DOI: 10.1371/journal.pntd.0003104.Peer-Reviewed Original ResearchConceptsBlood productsPlatelet transfusionsDengue patientsDirect costsDengue casesHealth systemLaboratory-confirmed dengue patientsCross-sectional census studyMedian hospitalization costNumber of hospitalizationsPublic health problemWorld Health Organization guidelinesHealth Organization guidelinesPrivate health systemHealth care systemDengue guidelinesHospitalized dengue casesHospitalized dengue patientsDengue illnessHospitalization costsTransfusion criteriaPatientsDengue hospitalizationsPrivate health care systemHealth problems